Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.

Kazamatsuri H, Chien CP, Cole JO.

Am J Psychiatry. 1973 Apr;130(4):479-83. No abstract available.

PMID:
4570750
2.

Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.

Kazamatsuri H, Chien C, Cole JO.

Arch Gen Psychiatry. 1972 Jul;27(1):100-3. No abstract available.

PMID:
4555826
3.

Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.

Kazamatsuri H, Chien C, Cole JO.

Arch Gen Psychiatry. 1972 Jul;27(1):95-9. No abstract available.

PMID:
4555831
4.

Methylphenidate in tardive dyskinesia.

Fann WE, Davis JM, Wilson IC.

Am J Psychiatry. 1973 Aug;130(8):922-4. No abstract available.

PMID:
4577471
5.

Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.

Huygens H, Vereecken JL, Tanghe A.

Psychiatr Neurol Neurochir. 1973 Jul-Aug;76(4):251-9. No abstract available.

PMID:
4581374
6.

Clinical observations of the treatment of tardive dyskinesia with haloperidol.

Frangos E, Christodoulides H.

Acta Psychiatr Belg. 1975 Jan;75(1):19-32.

PMID:
785948
7.

Tardive and withdrawal dyskinesia associated with haloperidol.

Jacobson G, Baldessarini RJ, Manschreck T.

Am J Psychiatry. 1974 Aug;131(8):910-3. No abstract available.

PMID:
4834709
8.

Therapeutic approaches to tardive dyskinesia. A review of the literature.

Kazamatsuri H, Chien C, Cole JO.

Arch Gen Psychiatry. 1972 Oct;27(4):491-9. Review. No abstract available.

PMID:
4116201
9.

Tetrabenazine in the treatment of extrapyramidal dyskinesias.

Gilligan BS, Wodak J, Veale JL, Munro OR.

Med J Aust. 1972 Nov 4;2(19):1054-6. No abstract available.

PMID:
4264609
10.

Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.

Pakkenberg H, Fog R.

Arch Neurol. 1974 Nov;31(5):352-3. No abstract available.

PMID:
4607088
11.

[Tardive dyskinesia. Synthetic-critical review and case contribution].

Campanini T, Catalano A, De Risio C, Forino V.

Ateneo Parmense Acta Biomed. 1977;48(1):41-60. Italian.

PMID:
324489
12.

Withdrawal of maintenance drugs with long-term hospitalized mental patients: a critical review.

Tobias LL, MacDonald ML.

Psychol Bull. 1974 Feb;81(2):107-25. Review. No abstract available.

PMID:
4149623
13.

Treatment of tardive dyskinesia. 3. Clinical efficacy of a dopamine competing agent, methyldopa.

Kazamatsuri H, Cole JO.

Arch Gen Psychiatry. 1972 Dec;27(6):824-7. No abstract available.

PMID:
4637899
14.

[Spontaneous oral dyskinesia. Successful treatment with tetrabenazine (author's transl)].

Schumm F, Dichgans J, Zeller E.

Arch Psychiatr Nervenkr (1970). 1981;230(4):315-23. German.

PMID:
7316728
15.

Tardive dyskinesia.

Schiele BC, Gallant D, Simpson G, Gardner EA, Cole JO.

Am J Orthopsychiatry. 1973 Jul;43(4):506 passim. No abstract available.

PMID:
4716664
16.

Prevention and management of tardive dyskinesia.

Crane GE.

Am J Psychiatry. 1972 Oct;129(4):466-7. No abstract available.

PMID:
5071149
17.

Tardive dyskinesia.

Simpson GM.

Br J Psychiatry. 1973 May;122(570):618. No abstract available.

PMID:
4717040
18.

Neurological consequences of psychotropic drug withdrawal in schizophrenic children.

Polizos P, Engelhardt DM, Hoffman SP, Waizer J.

J Autism Child Schizophr. 1973 Jul-Sep;3(3):247-53. No abstract available.

PMID:
4800390
19.

Tetrabenazine and movement disorders.

Asher SW, Aminoff MJ.

Neurology. 1981 Aug;31(8):1051-4.

PMID:
6455607
20.

Effect of lithium on neuroleptic-induced tardive dyskinesia compared with placebo in a double-blind cross-over trial.

Gerlach J, Thorsen K, Munkvad I.

Pharmakopsychiatr Neuropsychopharmakol. 1975 Mar;8(2):51-6.

PMID:
788002

Supplemental Content

Support Center